G. Mathis et al., HOMOGENEOUS IMMUNOASSAYS USING RARE-EARTH CRYPTATES AND TIME-RESOLVEDFLUORESCENCE - PRINCIPLES AND SPECIFIC ADVANTAGES FOR TUMOR-MARKERS, Anticancer research, 17(4B), 1997, pp. 3011-3014
We have developed a new type of long lived fluorescent tracer the rare
earth cryptates formed by the inclusion of a Eu3+ ion into the intra
molecular cavity of a macrobicyclic ligand containing bipyridine units
. This tracer is used in a new homogeneous assay format based on spect
ral and temporal selectivity as well as on an amplification of the cry
ptate Florescence. As a consequence of these features, the measurement
of the specific signal is totally shielded from media interaction and
corrected in real time for sample to sample optical variation. We sho
w the example of a PSA assay where an analytical sensitivity of 0.03 n
g/ml is obtained and an AFP assay where measurements in the first minu
tes of the incubation allow a rapid estimation of the AFP concentratio
n and therefore an immediate dilution of the samples if required These
results illustrate the performance of this new homogeneous method and
point out the specific advantages it allows in terms of sensitivity,
precision and flexibility. It is therefore particularly well adapted f
or the assay of analytes like tumor markers where both sensitivity and
wide dynamic range are needed.